This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Chinese AI company loses China's first court challenge over copyright infringement

By MLex Staff ( March 13, 2024, 08:37 GMT | Insight) -- A court in China has ruled against a Chinese artificial intelligence company operating a website with AI chat and drawing functions in a dispute over copyright infringement, setting the first judicial precedent of its kind in the country over emerging AI-generated content. The Guangzhou Internet Court ruled that the AI company, which wasn't identified, must immediately cease infringing the plaintiff company’s copyrights in the Japanese anime series Ultraman and take technical measures to prevent users from generating images that infringe the plaintiff's copyrights.A court in China has ruled against a Chinese artificial intelligence company operating a website with AI chat and drawing functions in a dispute over copyright infringement, setting the first judicial precedent of its kind in the country over emerging AI-generated content....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections